Dry eye disease is a condition that afflicts millions of people worldwide, causing constant discomfort and affecting their quality of life. One of the key culprits behind this condition is meibomian ...

Please provide your email address to receive an email when new articles are posted on . Eyes with meibomian gland dysfunction treated with vectored thermal pulsation experienced improved visible ...

Please provide your email address to receive an email when new articles are posted on . “Glaucoma medication is associated with changes in meibomian glands morphology, including decreased acinar area, ...

TEL AVIV, Israel--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today ...

Meibomitis is a chronic inflammation of the tiny oil glands that line your upper and lower eyelids. The meibomian glands release meibum, the special oil that helps lubricate your eyes and keep your ...

Meibomian gland dysfunction (MGD) is underdiagnosed and undertreated, with asymptomatic disease far more common than symptomatic disease. As the condition progresses, patients who were initially ...

Dry eye disease (DED) affects nearly 16 million Americans. This multifactorial condition, characterized by rapid tear evaporation or decreased tear production, can cause symptoms from eye irritation ...

TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage company developing innovative therapies for Meibomian gland dysfunction (MGD) and related eye ...

A team led by Mount Sinai researchers has identified stem cell populations and mechanisms underlying age-related degeneration ...